Evidence map›Paper›PMID 33425618›Full record

ArticlePlastic and reconstructive surgery. Global open2020

Analysis of Secondary Surgeries after Immediate Breast Reconstruction for Cancer Compared with Risk Reduction.

Stacey J Jones, Philip Turton, Rajgopal Achuthan, Brian V Hogan, Shireen N Mckenzie, Baek Kim

Open access · goldAbstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Stacey J JonesDepartment of Oncoplastic Breast and Reconstructive Surgery, St. James's University Hospital, Leeds, United Kingdom.
Philip TurtonDepartment of Oncoplastic Breast and Reconstructive Surgery, St. James's University Hospital, Leeds, United Kingdom.
Rajgopal AchuthanDepartment of Oncoplastic Breast and Reconstructive Surgery, St. James's University Hospital, Leeds, United Kingdom.
Brian V HoganDepartment of Oncoplastic Breast and Reconstructive Surgery, St. James's University Hospital, Leeds, United Kingdom.
Shireen N MckenzieDepartment of Oncoplastic Breast and Reconstructive Surgery, St. James's University Hospital, Leeds, United Kingdom.
Baek KimDepartment of Oncoplastic Breast and Reconstructive Surgery, St. James's University Hospital, Leeds, United Kingdom.
St James's University Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study sets out to compare reconstructive practice between patients undergoing immediate breast reconstruction (IBR) for cancer and those who opted for risk reduction (RR), with an emphasis on examining patterns of secondary surgery.

methodsData collection was performed for patients undergoing mastectomy and IBR at a teaching hospital breast unit (2013-2016).

resultsIn total, 299 patients underwent IBR (76% cancer versus 24% RR). Implant-based IBR rate was similar in both groups (58% cancer versus 63% RR). Reconstruction loss (5.3% cancer versus 4.2% RR) and complication (16% cancer versus 12.9% RR) rates were similar. Cancer patients were more likely to undergo secondary surgery (68.4% versus 56.3%;

conclusionsMost of the secondary surgeries were planned for cancer patients. However, complications led to a significantly higher rate of unplanned secondary surgery. Approximately 1 in 4 RR patients received unplanned secondary surgery, which may be driven by the desire to achieve an optimal aesthetic outcome.

Identifiers

PMID33425618
PMCPMC7787276
OpenAlexW3119713718

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.